NCT00529009已完成1 期
Pharmacokinetic Investigation of UDCA in Bile and Serum
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
To assess the bile acid composition of cystic bile and serum pharmaco¬kinetics after a 3-week treatment with UDCA and to correlate pharmacokinetic parameters of UDCA in bile and serum during steady state.
详细描述
see protocol
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •PBC or healthy
排除标准
- •pathology which does interfere with safety or PK of UDCA
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Pharmacokinetics of UDCA in serum and bile in patients with early stage PBC (stage I-III) and in healthy volunteersearly stage primary biliary cirrhosis10019654PBCNL-OMON31024Dr. Falk Pharma GmbH10
进行中（未招募）
不适用
Pharmacokinetics of UDCA in serum and bile in patients with early stage PBC (stage I-III) and in healthy volunteersPrimary Biliary Cirrhosis Stage I-IIIMedDRA version: 12.1Level: LLTClassification code 10036680Term: Primary biliary cirrhosisEUCTR2006-003712-22-DEDr. Falk Pharma GmbH24
已完成
2 期
Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid ArthritisRheumatoid ArthritisNCT05973370Tanta University60
已完成
1 期
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety PhenotypeHealthyObesityNCT05314374Mayo Clinic35
已完成
不适用
The Effect of UrsodeoXyCholicacid (UDCA) and ezetimibe on total faecal steRol ExcreTion and plasma lipid lEvels1001980610013317Familial hypercholesterolemiaNL-OMON47926Academisch Medisch Centrum (AMC)20